Methods, kits and devices for measuring extracellular pyridine nucleotide
AssigneeCharite-Universitaetsmedizin Berlin
InventorsAnnekatrin Leder, Philipp Brunnbauer, Felix Krenzien
Life of this patent
Estimating the term…
Loading patent…
AssigneeCharite-Universitaetsmedizin Berlin
InventorsAnnekatrin Leder, Philipp Brunnbauer, Felix Krenzien
Estimating the term…
Disclosed herein are methods, devices and kits suitable for high throughput screenings of extracellular pyridine nucleotide levels, such as NAD+ levels which are suitable for monitoring pyridine nucleotide induced slowdown of not only pathogenesis of multiple systemic diseases but also aging. In particular, assaying methods quantifying extracellular pyridine nucleotide(s), such as NAD+, in the low micromolar to the low nanomolar range in a sample that may have been subjected to long term storage are disclosed using a two-step enzymatic cycling reaction employing an oxidoreductase such as alcohol dehydrogenase. A modified revised simulated body fluid is also disclosed that is employed as a standard matrix to optimise enzymatic activity, linearity and/or sensitivity of the methods, devices and kits.
Method for determining a concentration of oxidized extracellular pyridine nucleotide (ePNox) in a body fluid of a subject, comprising:
Dependencies are inferred from the claim text.